Hyperoxalemia: Clinical Trials

3 trials for Hyperoxalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow Hyperoxalemia: new trials by email Literature Review of Hyperoxalemia trials Research Report on Hyperoxalemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Lumasiran, 0.9% Sodium Chloride (placebo) - Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2UnknownCharite University, Berlin, Germany502024-04-142024-08-21
Plasma Oxalate in Patient With Short Bowel
Blood sampling, Urine sampling, Pulse Wave Velocity (PWV) measurement - Short Bowel Syndrome, Hyperoxaluria
CompletedHospices Civils de Lyon472020-02-272022-07-21
Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
ALLN-177 - Enteric Hyperoxaluria, Primary Hyperoxaluria
Phase 2CompletedAllena Pharmaceuticals152018-07-172020-12-30

Narrower conditions

Cardiovascular Diseases (1)  ·  Hyperoxaluria (1)  ·  Hyperoxaluria, Primary (1)  ·  Kidney Calculi (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Calculi (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hyperoxaluria (1)  ·  Intestinal Diseases (1)

Interventions

Blood Specimen Collection (1)  ·  Sodium Chloride (1)  ·  Weights and Measures (1)  ·  lumasiran (1)  ·  oxalate decarboxylase (1)  ·  reloxaliase (1)

Sponsors

Allena Pharmaceuticals (1)  ·  Charite University, Berlin, Germany (1)  ·  Hospices Civils de Lyon (1)

Countries

Germany (2)  ·  France (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

David Clark, MD (1)  ·  Felix Knauf, MD (1)  ·  Sandrine Lemoine, MD (1)

NIH funding

2017 (1)